North America Molecular Diagnostics for Infectious Disease Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Molecular Diagnostics for Infectious Disease Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Molecular Diagnostics for Infectious Disease Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Molecular Diagnostics for Infectious Disease Market Regional Analysis

6.2 North America Molecular Diagnostics for Infectious Disease Market Revenue 2020-2030 (US$ Million)

6.3 North America Molecular Diagnostics for Infectious Disease Market Forecast Analysis

7. North America Molecular Diagnostics for Infectious Disease Market Analysis – by Type

7.1 Point-of-Care Testing and Laboratory Testing

7.1.1 Overview
7.1.2 Point-of-Care Testing and Laboratory Testing: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Molecular Diagnostics for Infectious Disease Market Analysis – by End User

8.1 Human Testing and Vet Testing

8.1.1 Overview
8.1.2 Human Testing and Vet Testing: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Molecular Diagnostics for Infectious Disease Market Analysis – by Application

9.1 Detection of Single Pathogen

9.1.1 Overview
9.1.2 Detection of Single Pathogen: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Detection of Two or More Pathogens

9.2.1 Overview
9.2.2 Detection of Two or More Pathogens: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Evaluation of Emerging Novel Infections

9.3.1 Overview
9.3.2 Evaluation of Emerging Novel Infections: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.4 Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker

9.4.1 Overview
9.4.2 Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.5 Antimicrobial Resistance Profiling

9.5.1 Overview
9.5.2 Antimicrobial Resistance Profiling: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.6 Patient stratification

9.6.1 Overview
9.6.2 Patient stratification: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.7 Drug Regimen Selection

9.7.1 Overview
9.7.2 Drug Regimen Selection: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.8 Toxicity Avoidance

9.8.1 Overview
9.8.2 Toxicity Avoidance: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.9 Therapeutic Monitoring

9.9.1 Overview
9.9.2 Therapeutic Monitoring: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.10 Detection of Predisposition to Disease

9.10.1 Overview
9.10.2 Detection of Predisposition to Disease: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Molecular Diagnostics for Infectious Disease Market Analysis – by Disease Type

10.1 Sepsis

10.1.1 Overview
10.1.2 Sepsis: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Prosthetic Joint Infection

10.2.1 Overview
10.2.2 Prosthetic Joint Infection: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.3 Endocarditis

10.3.1 Overview
10.3.2 Endocarditis: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.4 STDs

10.4.1 Overview
10.4.2 STDs: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.5 Mononucleosis

10.5.1 Overview
10.5.2 Mononucleosis: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.6 Group A Streptococcus

10.6.1 Overview
10.6.2 Group A Streptococcus: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.7 Sepsis

10.7.1 Overview
10.7.2 Sepsis: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.8 Prosthetic Joint Infection

10.8.1 Overview
10.8.2 Prosthetic Joint Infection: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.9 Endocarditis

10.9.1 Overview
10.9.2 Endocarditis: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.10 STDs

10.10.1 Overview
10.10.2 STDs: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.11 Chlamydia

10.11.1 Overview
10.11.2 Chlamydia: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.12 Gastrointestinal Infection

10.12.1 Overview
10.12.2 Gastrointestinal Infection: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.13 Tuberculosis

10.13.1 Overview
10.13.2 Tuberculosis: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.14 H1N1 Virus

10.14.1 Overview
10.14.2 H1N1 Virus: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. North America Molecular Diagnostics for Infectious Disease Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 US: North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
11.2.1.1.2 US: North America Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
11.2.1.1.3 US: North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
11.2.1.1.4 US: North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type

11.2.1.2 Canada: North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Canada: North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
11.2.1.2.2 Canada: North America Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
11.2.1.2.3 Canada: North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
11.2.1.2.4 Canada: North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type

11.2.1.3 Mexico : North America Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 Mexico : North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
11.2.1.3.2 Mexico : North America Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
11.2.1.3.3 Mexico : North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
11.2.1.3.4 Mexico : North America Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 bioMerieux SA

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Bruker Corp

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Danaher Corp

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 DiaSorin SpA

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 F. Hoffmann-La Roche Ltd

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Hologic Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Siemens Healthineers AG

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Thermo Fisher Scientific Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Molecular Diagnostics for Infectious Disease Market